HPV Vaccination May Cut Risk for CIN2+ Recurrence

FRIDAY, Aug. 5, 2022 -- Human papillomavirus (HPV) vaccination seems to reduce the risk for cervical intraepithelial neoplasia grade 2 or higher (CIN2+) recurrence, according to a review published online Aug. 3 in The BMJ. Konstantinos S....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news